MIAMI--(BUSINESS WIRE)--May 29, 2012-- SafeStitch Medical(R), Inc.

(OTCBB: SFES), is pleased to announce that it has officially changed the name of the AMID Stapler(R) to AMID(TM) Hernia Fixation Device to better describe the functionalities of the device.

"We believe the distinct features of the AMID Hernia Fixation Device offer improved functionality, including the unique 45 degree angle head, mesh manipulators and staple counter when compared to a standard medical device stapler. We are excited to offer this easy-to-use tool to health care professionals," said Jeffrey Spragens, President and CEO of SafeStitch Medical.

The AMID Hernia Fixation Device was created to offer an innovative alternative to manual suturing for inguinal hernia repair using the Lichtenstein method. The design fixates mesh by delivering staples in a parallel plane to the femoral vessels, which may help avoid vascular injury. The AMID Hernia Fixation Device allows for mesh manipulation, mesh fixation and skin closure.

Dr. Parviz Amid, inventor of the AMID Hernia Fixation Device, Clinical Professor of Surgery at UCLA, cofounder of the Lichtenstein Hernia Institute in 1986, and Executive Director of Lichtenstein Amid Hernia Clinic at UCLA, stated, "The unique features of mesh manipulators and angled head help ease the open hernia repair procedure." The AMID Hernia Fixation Device is sold nationwide.

About SafeStitch Medical, Inc.

Miami, Florida-based SafeStitch Medical, Inc. is a publicly traded medical device company founded by Charles J. Filipi M.D. and Jeffrey G. Spragens, along with Creighton University, in 2005, to develop a prototype for a minimally invasive obesity procedure. In the summer of 2006, Phillip Frost M.D., Chairman and CEO of OPKO Health, Inc. and Jane Hsiao Ph.D., Vice-Chairman and Chief Technical Officer of OPKO Health, Inc. became partners in SafeStitch Medical, Inc. and expanded SafeStitch's mission to develop and market the best in class disposable medical devices to advance minimally invasive surgery for hernia repair, treatment of obesity and other gastroesophageal disorders. Information about the Company may be found on its website at:

This press release contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipate," "believes," "should," "intends," "estimates," and other words of similar meaning, including statements regarding our product development and commercialization efforts, and our ability to significantly improve clinical outcomes in patients, as well as other non-historical statements about our expectations, beliefs or intentions regarding our business, technologies and products, financial condition, strategies or prospects. Many factors, including those described herein and in our filings with the Securities and Exchange Commission, could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include: whether the AMID Hernia Fixation Device offers improved functionality when compared to a standard medical device stapler; whether the AMID Hernia Fixation Device may help avoid vascular injury; and whether unique features of mesh manipulators and angled head help ease the open hernia repair procedure. The forward-looking statements contained in this press release speak only as of the date the statements were made, and we do not undertake any obligation to update forward-looking statements, except as required under applicable law. We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA.

Photos/Multimedia Gallery Available: CONTACT: SafeStitch Medical, Inc.


Copyright Business Wire 2012 PUB: 05/29/2012 04:00 PM/DISC: 05/29/2012 04:00 PM